Back to Trades
Davis Todd C
Chief Executive OfficerDirectorCIK 0001392029
Total Volume
$7.4M
6 filings
Purchases
$1000.0K
2 buy txns
Sales
$0
0 sell txns
Net Activity
$1000.0K
net bought
Profile
- Filings
- 6
- Buy transactions
- 2
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Davis Todd C, Chief Executive Officer, Director, has filed 6 SEC reports (2025–2026), spread across 3 companies, totaling $7.4M in disclosed volume. Weighing $1000.0K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $1000.0K in Pelthos Therapeutics Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jul 6 | LGND LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer, Director | Other | $21.2K |
| Jun 15 | PTHS Pelthos Therapeutics Inc. | Davis Todd C | Director | Buy | $1000.0K |
| Jun 12 | PVLA PALVELLA THERAPEUTICS, INC. | Davis Todd C | Director | Award | $306.6K |
| Apr 1 | PTHS Pelthos Therapeutics Inc. | Davis Todd C | Director | Grant | $0 |
| Feb 18 | LGND LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer, Director | Grant | $6.0M |
| Dec 8 | LGND LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer, Director | Gift | $0 |
6 filings